NCT07355569

Brief Summary

This study has been designed as a randomized controlled trial including women invited to a national screening program for breast cancer in Norway, BreastScreen Norway in 2025. The program invites women aged 50-69 to biennial screening mammography. The study includes two substudies with the intervention of sending an SMS notification three days prior to the screening appointment in the first substudy and two days prior to the screening appointment in second study. The comparison is made between the study groups, where women are sent an SMS notification two or three days prior to their scheduled screening appointment and the control groups where women will not be sent an SMS notification about a scheduled screening appointment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
133,770

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 5, 2026

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 21, 2026

Completed
Last Updated

January 23, 2026

Status Verified

December 1, 2025

Enrollment Period

10 months

First QC Date

January 5, 2026

Last Update Submit

January 21, 2026

Conditions

Keywords

breast cancer screeningSMS notificationattendance

Outcome Measures

Primary Outcomes (1)

  • Screening attendance

    Attendance after a routine or reminder invitation, with and without an SMS notification

    Three months (180 days) after scheduled date for a screening examination following a routine invitation or three months (180 days) after a reminder was posted.

Study Arms (2)

Study group

EXPERIMENTAL

The intervention was an SMS notification sent before the scheduled appointment for mammographic screening. Women in the study group was linked to the Common Contact Register in Norway (CCRN) to obtain phone numbers for sending SMS notification prior to the scheduled appointment. Phone numbers are registered in CCRN when users log into public online services through an electronic ID. Inclusion in this registry is voluntary. The personal identification number of the women in the study group was used to obtain their phone number. In study group 1 women were linked to the CCRN and those registered were sent an SMS notification three days prior to the scheduled routine screening appointment during January-March 2025. Women in study group 2 were sent an SMS notification two days prior to the scheduled routine screening appointment during April-June 2025.

Other: SMS notification

Control group

NO INTERVENTION

Women in the control group did not receive any SMS notification before the scheduled appointment to mammographic screening. The women in the control group were not linked to the NCCR and were not available or sent an SMS notification during the study periods, January-March 2025 (control group 1) and women who were not sent an SMS notification during April-June 2025 (control group 2).

Interventions

Available in the NCCR and sent an SMS notification three or two days prior to a scheduled screening appointment

Study group

Eligibility Criteria

Age50 Years - 71 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • women invited to BreastScreen Norway residing in the South-Eastern, Central, and Northern Norway Regional Health Authorities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Norwegian Institute of Public Health

Oslo, Oslo County, 222, Norway

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Model Details: Simple 1:1 randomization
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 5, 2026

First Posted

January 21, 2026

Study Start

January 10, 2025

Primary Completion

October 31, 2025

Study Completion

October 31, 2025

Last Updated

January 23, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Research data, including participant data used can only be requested from https://helsedata.no/, given the legal basis in Articles 6 and 9 of the GDPR and that the processing is in accordance with Article 5 of the GDPR, as well as Norwegian legislation.

Locations